Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2025-12-28 @ 1:09 AM
Study NCT ID:
NCT01068795
Status:
COMPLETED
Last Update Posted:
2016-02-23
First Post:
2010-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome
Sponsor:
HaEmek Medical Center, Israel
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2015-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-20
First Submit QC Date:
None
Study First Post Date:
2010-02-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-20
Last Update Post Date:
2016-02-23
Last Update Post Date Type:
ESTIMATED